The relationship of breast cancer prognosis and serum MTDH concentration

Multi-factor Analysis of Breast Cancer and MTDH expression in Breast Cancer Micro-metastasis

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-09000356

Enrollment

Unknown

Registered

2009-03-19

Start date

2009-02-18

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

Female

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. All the patients have not radiotherapy, chemotherapy and endocrine therapy before hospitalized, confirmed breast cancer through pathologically diagnosed, and excluded the possibility of suffering from other malignant tumors; 2. All of them agreed to chemotherapy after surgery; 3. All of them known the purpose of this study and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Important organs dysfunction,there are surgery or/and chemotherapy contraindications; 2. Emerge mental symptoms, those who can not meet to follow-up reseach; 3. Have radiotherapy, chemotherapy and endocrine therapy before hospitalized, etc.

Design outcomes

Primary

Measure	Time frame
Mortality;MTDH;Survival with cancer;	—

Secondary

Measure	Time frame
relapse rate of breast cancer;Metastasis rate of breast cancer;	—

Countries

China

Contacts

Public ContactZheng Bao

wangmomo1983@sohu.com+86 0734 8399028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026